跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
开浦兰 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Levetiracetam Concentrated Solution for Injection
Approved
化学药品
Levetiracetam Concentrated Solution for Injection
UCB-Pharma SA
🇨🇳 National Medical Products Administration
Approval Date
Apr 20, 2022
Approval ID
8HqqslYYHIF
Company
UCB-Pharma SA
Type
化学药品
Approval Details
Approval Id
8HqqslYYHIF
Approval Number
国药准字HJ20170341
Generic Name
左乙拉西坦注射用浓溶液
Generic Name En
Levetiracetam Concentrated Solution for Injection
Trade Name
开浦兰
Drug Type
化学药品
Dosage Form
注射剂
Strength
5ml:500mg
Reg Date
2022-04-20
Expired Date
2027-04-19
Company Name
UCB-Pharma SA
Production Company Name
PATHEON ITALIA SPA
Company Detail Path
/organization/ucb-pharma-sa-switzerland
Production Company Detail Path
/organization/patheon-italia-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 20, 2022
Approval ID
8HqqslYYHIF
Type
化学药品
Back to NMPA Approvals
